- Point-of-Care Testing (POCT) devices play a vital role in delivering rapid diagnostic results at or near the site of patient care, significantly enhancing clinical decision-making across various healthcare settings. These tests are widely used in managing chronic conditions, infectious diseases, and emergency care
- The demand for POCT solutions in the GSA and Benelux regions is primarily driven by the rising burden of chronic diseases, growing elderly population, and a strong push for decentralized and patient-centric healthcare models
- Germany is expected to dominate the POCT market with a share of 28.04%, in the region due to its well-established healthcare infrastructure, high diagnostic throughput, and adoption of advanced medical technologies
- The Benelux countries are projected to witness strong market growth driven by favorable government initiatives, rising healthcare expenditure, and increasing adoption of POCT in both clinical and homecare environments
- The blood glucose testing segment with a share 34.08% is anticipated to lead the POCT market in the region, driven by the high prevalence of diabetes and the demand for real-time monitoring tools that empower patients in disease management
